Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ocaliva Dosing Problems Lead To FDA Black Box Warning February 2, 2018 Irvin Jackson Add Your Comments The FDA is requiring a new “black box” warning about the risk of medication errors with Ocaliva, a liver disease drug that has been linked to at least 19 deaths and a number of reports involving serious liver injury. In a drug safety communication issued on February 1, the agency announced that the strongest label warning will be added to the drug, clarifying current recommendations for screening, dosing, monitoring and managing patients using Ocaliva. The new requirements also call for a medication guide to inform patients about the dosing problems. Ocaliva (obeticholic acid) is an Intercept Pharmaceuticals drug first approved in May 2016. It is used to treat primary billary cholangitis (PBC), a rare and chronic form of liver disease. PBC can cause inflammation and destruction of bile ducts in the liver, resulting the bile to build up and damage the liver over time. Ocaliva Recall lawsuit Did you or a loved one Take Ocaliva? Lawsuits are being investigated for former Ocaliva users who suffered liver failure, rapid cirrhosis progression, hospitalization, or required a liver transplant after taking the drug. Settlement benefits may be available. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Ocaliva Recall lawsuit Did you or a loved one Take Ocaliva? Lawsuits are being investigated for former Ocaliva users who suffered liver failure, rapid cirrhosis progression, hospitalization, or required a liver transplant after taking the drug. Settlement benefits may be available. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although it has been on the market for less than two years, Ocaliva has been linked to 19 deaths and 11 cases of serious liver injury. In eight of the deaths the FDA investigated, seven involved worsening PBC. Seven of the cases also involved patients suffering moderate to severe decreased liver function after taking 5 mg of Ocaliva daily. The problem with Ocaliva stems from recommendations that individuals with moderate to severe decreased liver function should take no more than 10 mg of the drug twice weekly. If patients with that level of impairment are taking 5 mg of Ocaliva daily, that puts them at 35 mg per week. While taking 10 mg twice weekly, as recommended, means that patients should only be taking 20 mg per week. The FDA first announced the Ocaliva liver concerns in a September 2017 drug safety communication. The agency is calling for health care professionals to follow the dosing regimen on the drug label, and to routinely monitor patients for biochemical response, tolerability, and primary billary cholangitis progression. They should re-evaluate the Child-Pugh classification used to determine dosing if they believe dosage adjustment is necessary. Patients at risk of liver decompensation, and those with signs of worsening liver function, should be closely monitored, according to the recommendations. The FDA advises patients to contact their health care professional if they are taking Ocaliva if they develop: New or worsening severe skin itching New or worsening fatigue Abdominal pain Abdominal swelling Diarrhea Weight loss Decreased appetite Nausea and vomiting Behavioral changes, confusion, or anxiety Yellow eyes or skin Bloody stools The FDA urges health care professionals and patients to report any Ocaliva side effects to the FDA’s MedWatch adverse event reporting program. 2025 Ocaliva Recall Lawsuit Update On September 11, 2025, Intercept Pharmaceuticals withdrew Ocaliva from the U.S. market at the FDA’s request, following years of safety concerns that began with a Boxed Warning in February 2018 over fatal dosing errors. The withdrawal came after mounting reports of liver failure in patients who should never have received standard dosing due to impaired liver function. For former users left with liver injuries, lawyers are now investigating the potential for Ocaliva lawsuits, which may help obtain financial compensation from the drug makers, for failing to adequately warn about the potential side effects of Ocaliva. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Intercept Pharmaceuticals, Liver Damage, Liver Injury, Medication Error, Ocaliva More Ocaliva Lawsuit Stories Ocaliva Liver Side Effects Are Higher for Patients Who Didn’t Respond to Drug: Study October 14, 2025 Ocaliva Recall Issued Due to Liver Injury Risks September 12, 2025 FDA Warns of Ocaliva Liver Injury Risks Linked to Autoimmune Disorder Drug December 13, 2024 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: today) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. As complication reports rise and more women undergo revision surgery, lawsuits are now being investigated against companies that promoted mesh for off-label breast procedures despite FDA warnings and no breast-specific safety data. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) With Roblox Being Sued by Families Nationwide, JPML To Consider Centralizing Claims (Posted: yesterday) A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation. MORE ABOUT: ROBLOX LAWSUITInternet Gaming Disorder May Affect 1 in 10 Adolescent Boys: Study (10/15/2025)Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (10/10/2025)Roblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025) MDL Judge Calls for New Census of Suboxone Tooth Decay Lawsuits (Posted: 2 days ago) A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITTramadol Side Effects Outweigh Pain Management Benefits, Study Finds (10/15/2025)Gabapentin Use Increasing Along With Abuse Concerns: Report (10/09/2025)Gabapentin Prescriptions Could Be Leading to Growing Abuse Epidemic: Study (09/17/2025)
Ocaliva Liver Side Effects Are Higher for Patients Who Didn’t Respond to Drug: Study October 14, 2025
Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use (Posted: today) Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation. As complication reports rise and more women undergo revision surgery, lawsuits are now being investigated against companies that promoted mesh for off-label breast procedures despite FDA warnings and no breast-specific safety data. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
With Roblox Being Sued by Families Nationwide, JPML To Consider Centralizing Claims (Posted: yesterday) A panel of federal judges will decide in December whether to consolidate all claims brought by parents who allege that Roblox facilitated child sexual exploitation into a multidistrict litigation. MORE ABOUT: ROBLOX LAWSUITInternet Gaming Disorder May Affect 1 in 10 Adolescent Boys: Study (10/15/2025)Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (10/10/2025)Roblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)
MDL Judge Calls for New Census of Suboxone Tooth Decay Lawsuits (Posted: 2 days ago) A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITTramadol Side Effects Outweigh Pain Management Benefits, Study Finds (10/15/2025)Gabapentin Use Increasing Along With Abuse Concerns: Report (10/09/2025)Gabapentin Prescriptions Could Be Leading to Growing Abuse Epidemic: Study (09/17/2025)